Label: SCANTILY PAD- dermala acne treatment liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 3, 2021

If you are a consumer or patient please visit this version.

View All Sections
  • Use

    For the treatment of Acne.

  • Active Ingredient

    Salicylic acid 1% ...........Acne Treatment

  • Warning

    WARNINGS For external use only. Skin irritation and dryness is more likely to occur when using this product if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

  • Incative ingredients

    INACTIVE INGREDIENTS Organic Aloe vera, organic grain alcohol, cocamidopropyl dimethylamine, SE Microbiome ComplexTM, sodium hydroxide, organic lemon essential oil.

  • DOSAGE & ADMINISTRATION

    DIRECTIONS Cleanse the skin. Use one pad to apply a thin layer of solution to affected areas. Start with one application daily, then increase to two times per day (morning and evening). If dryness or peeling occurs, reduce application to once a day or every other day. Test on a small area of skin before applying to face. If eye contact occurs, flush thoroughly with water.

  • children

    keep out of reach of children

  • indications and usage

    For the treatment of Acne

  • Label

    Label

  • INGREDIENTS AND APPEARANCE
    SCANTILY PAD 
    dermala acne treatment liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65112-268
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.01 mg  in 1 mg
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R) 0.8 mg  in 1 mg
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65112-268-0150 mg in 1 JAR; Type 0: Not a Combination Product05/04/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333D05/04/2021
    Labeler - I Shay Cosmetics Inc (151582384)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!